![George Yu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
George Yu
Plus aucun poste en cours
Profil
George Yu is the founder of Medisun Precision Medicine Ltd.
founded in 2012, where he held the titles of President, Chief Executive Officer, CFO & Director from 2014 to 2017.
He was also the President, Chief Executive Officer, CFO & Director of Logiq, Inc. in 2012 and the Chief Financial Officer & Director of SinoBiomed, Inc. from 2010 to 2011.
Dr. Yu holds a doctorate from Eberhard Karls Universität Tübingen and an MBA from Columbia Business School.
Anciens postes connus de George Yu
Sociétés | Poste | Fin |
---|---|---|
MEDISUN PRECISION MEDICINE LTD. | Directeur Général | 19/01/2017 |
SinoBiomed, Inc.
![]() SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | President | 16/06/2011 |
LOGIQ, INC. | President | 20/12/2012 |
Formation de George Yu
Eberhard Karls Universität Tübingen | Doctorate Degree |
Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
LOGIQ, INC. | Technology Services |
Entreprise privées | 2 |
---|---|
SinoBiomed, Inc.
![]() SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Health Technology |
Medisun Precision Medicine Ltd.
![]() Medisun Precision Medicine Ltd. BiotechnologyHealth Technology Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands. | Health Technology |